Search Results - yezi+zhu

1 Results

Sort By:

Androgen Receptor and AR-V7 Knock-out Lines from the LNCaP95 Cell Line

Unmet NeedProstate cancer is considered the most common type of cancer in men with approximately 249,000 new cases and an estimated 34,130 deaths in 2021 (see ACS). Prostate cancer treatment is dependent on tumor staging with early stage intervention including surgery or radiotherapy and later stage management by androgen deprivation therapy (see Uptodate)....

Published: 3/14/2025 | Inventor(s): Jun Luo, Yezi Zhu, Changxue Lu

Keywords(s):

Category(s): Clinical and Disease Specializations > Oncology > Prostate Cancer, Technology Classifications > Research Tools > Cell Lines